Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy [NA]

View source ↗

Summary

A clinical trial is evaluating whether a Force Modulating Tissue Bridge Device can reduce hypertrophic scar formation after gender-affirming mastectomy; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Force Modulating Tissue Bridge Device

Snippet

Sponsor: University of California, San Francisco | Conditions: Gender Dysphoria, Mastectomy | NA | Status: RECRUITING